Alternative pathway of complement in multiple myeloma
β Scribed by Eric H. Kraut; Arthur L. Sagone Jr.
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 544 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The complement inhibitor, Crry, which blocks both the classical and alternative pathways, alleviates CNS disease in the lupus model, MRL/MpJβ__Tnfrsf6lpr__ (MRL/__lpr__) mice. To understand the role of the alternative pathway, we studied mice deficient in a key alternative pathway prote
Atypical hemolytic uremic syndrome (aHUS) is characterized by acute renal failure, thrombocytopenia and microangiopathic hemolytic anemia, and occurs with an estimated incidence in the USA of 2 per 1,000,000. Disease pathogenesis is related to dysregulation of the alternative pathway (AP) of the com